Fang-Yu Lee

566 total citations
15 papers, 507 citations indexed

About

Fang-Yu Lee is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Fang-Yu Lee has authored 15 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Fang-Yu Lee's work include Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (3 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). Fang-Yu Lee is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (3 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). Fang-Yu Lee collaborates with scholars based in Taiwan, United States and Czechia. Fang-Yu Lee's co-authors include Che‐Ming Teng, Sheng-Chu Kuo, Shiow‐Lin Pan, Jih‐Hwa Guh, Ya-Ling Chang, Li-Jiau Huang, Chieh-Yu Peng, Kenneth F. Bastow, Shih‐Wei Wang and Kuo‐Hsiung Lee and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Biochemical Pharmacology.

In The Last Decade

Fang-Yu Lee

15 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fang-Yu Lee Taiwan	13	295	180	79	79	40	15	507
Ronald Grigg United Kingdom	10	255 0.9×	121 0.7×	108 1.4×	41 0.5×	24 0.6×	11	512
Jean‐François Gaussin Belgium	7	343 1.2×	134 0.7×	114 1.4×	80 1.0×	59 1.5×	10	587
Nuria Ajenjo Spain	9	423 1.4×	80 0.4×	136 1.7×	81 1.0×	16 0.4×	12	598
Irida Kastrati United States	14	376 1.3×	176 1.0×	203 2.6×	144 1.8×	42 1.1×	35	771
Yulia Aleksandrova Russia	12	280 0.9×	79 0.4×	85 1.1×	80 1.0×	40 1.0×	49	502
Scilla Latini Denmark	10	267 0.9×	140 0.8×	153 1.9×	90 1.1×	13 0.3×	13	707
Shala L. Thomas United States	6	357 1.2×	77 0.4×	118 1.5×	72 0.9×	39 1.0×	6	504
Elena Mariotto Italy	16	263 0.9×	239 1.3×	123 1.6×	69 0.9×	31 0.8×	35	619
Philipp Y. Maximov United States	17	293 1.0×	101 0.6×	204 2.6×	94 1.2×	52 1.3×	26	760
Katayoun A. Jessen United States	9	216 0.7×	129 0.7×	82 1.0×	23 0.3×	63 1.6×	18	465

Countries citing papers authored by Fang-Yu Lee

Since Specialization

Citations

This map shows the geographic impact of Fang-Yu Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fang-Yu Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fang-Yu Lee more than expected).

Fields of papers citing papers by Fang-Yu Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fang-Yu Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fang-Yu Lee. The network helps show where Fang-Yu Lee may publish in the future.

Co-authorship network of co-authors of Fang-Yu Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Fang-Yu Lee. A scholar is included among the top collaborators of Fang-Yu Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fang-Yu Lee. Fang-Yu Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Peng, Chieh-Yu, Shiow‐Lin Pan, An‐Chi Tsai, et al.. (2010). The Indazole Derivative YD-3 Specifically Inhibits Thrombin-Induced Angiogenesis In Vitro and In Vivo. Shock. 34(6). 580–585. 5 indexed citations

Liu, Yi-Nan, Shiow‐Lin Pan, Chieh-Yu Peng, et al.. (2008). YC-1 INDUCES HEAT SHOCK PROTEIN 70 EXPRESSION AND PREVENTS OXIDIZED LDL-MEDIATED APOPTOSIS IN VASCULAR SMOOTH MUSCLE CELLS. Shock. 30(3). 274–279. 11 indexed citations

Nakagawa‐Goto, Kyoko, Seikou Nakamura, Kenneth F. Bastow, et al.. (2007). Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: Evaluation of novel conjugates as cytotoxic agents. Bioorganic & Medicinal Chemistry Letters. 17(10). 2894–2898. 22 indexed citations

Chen, Chun‐Jen, Mei‐Hua Hsu, Li-Jiau Huang, et al.. (2007). Anticancer mechanisms of YC-1 in human lung cancer cell line, NCI-H226. Biochemical Pharmacology. 75(2). 360–368. 43 indexed citations

Nakagawa‐Goto, Kyoko, Koji Yamada, Seikou Nakamura, et al.. (2007). Antitumor agents. 258. Syntheses and evaluation of dietary antioxidant—taxoid conjugates as novel cytotoxic agents. Bioorganic & Medicinal Chemistry Letters. 17(18). 5204–5209. 42 indexed citations

Pan, Shiow‐Lin, Jih‐Hwa Guh, Chieh-Yu Peng, et al.. (2005). A potential role of YC-1 on the inhibition of cytokine release in peripheral blood mononuclear leukocytes and endotoxemic mouse models. Thrombosis and Haemostasis. 93(5). 940–948. 29 indexed citations

Huang, Li-Jiau, et al.. (2005). Synthesis of N2-(substituted benzyl)-3-(4-methylphenyl)indazoles as novel anti-angiogenic agents. Bioorganic & Medicinal Chemistry. 14(2). 528–536. 75 indexed citations

Pan, Shiow‐Lin, Jih‐Hwa Guh, Chieh-Yu Peng, et al.. (2005). YC-1 [3-(5′-Hydroxymethyl-2′-furyl)-1-benzyl Indazole] Inhibits Endothelial Cell Functions Induced by Angiogenic Factors in Vitro and Angiogenesis in Vivo Models. Journal of Pharmacology and Experimental Therapeutics. 314(1). 35–42. 54 indexed citations

Wang, Shih‐Wei, Shiow‐Lin Pan, Jih‐Hwa Guh, et al.. (2005). YC-1 [3-(5′-Hydroxymethyl-2′-furyl)-1-benzyl Indazole] Exhibits a Novel Antiproliferative Effect and Arrests the Cell Cycle in G0-G1 in Human Hepatocellular Carcinoma Cells. Journal of Pharmacology and Experimental Therapeutics. 312(3). 917–925. 48 indexed citations

10.

Liu, Yi-Nan, Shiow‐Lin Pan, Chieh-Yu Peng, et al.. (2005). YC-1 [3-(5′-Hydroxymethyl-2′-furyl)-1-benzyl Indazole] Inhibits Neointima Formation in Balloon-Injured Rat Carotid through Suppression of Expressions and Activities of Matrix Metalloproteinases 2 and 9. Journal of Pharmacology and Experimental Therapeutics. 316(1). 35–41. 30 indexed citations

11.

Huang, Yao-Ting, Shiow‐Lin Pan, Jih‐Hwa Guh, et al.. (2005). YC-1 suppresses constitutive nuclear factor-κB activation and induces apoptosis in human prostate cancer cells. Molecular Cancer Therapeutics. 4(10). 1628–1635. 49 indexed citations

12.

Guh, Jih‐Hwa, et al.. (2004). The indazole derivative YD-3 inhibits thrombin-induced vascular smooth muscle cell proliferation and attenuates intimal thickening after balloon injury. Thrombosis and Haemostasis. 92(12). 1232–1239. 17 indexed citations

13.

Ohtsu, Hironori, Yuka Nakanishi, Kenneth F. Bastow, Fang-Yu Lee, & Kuo Hsiung Lee. (2003). Antitumor agents 216. Synthesis and evaluation of paclitaxel–camptothecin conjugates as novel cytotoxic agents1. Bioorganic & Medicinal Chemistry. 11(8). 1851–1857. 25 indexed citations

14.

Lien, Jin‐Cherng, Fang-Yu Lee, Li-Jiau Huang, et al.. (2002). 1-Benzyl-3-(5‘-hydroxymethyl-2‘-furyl)indazole (YC-1) Derivatives as Novel Inhibitors Against Sodium Nitroprusside-Induced Apoptosis. Journal of Medicinal Chemistry. 45(23). 4947–4949. 21 indexed citations

15.

Shi, Qian, Hui-Kang Wang, Kenneth F. Bastow, et al.. (2001). Antitumor agents 210. synthesis and evaluation of taxoid–epipodophyllotoxin conjugates as novel cytotoxic agents. Bioorganic & Medicinal Chemistry. 9(11). 2999–3004. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact